Innovatie in de Sierteelt & het Businessmodel, door Sander de Leeuw, 16 nov 2011

•

1 like•267 views

KennisKring Amsterdam

'Consolidatie in de logistiek'

CONSOLIDATIE IN DE LOGISTIEK

ONTWIKKELINGEN IN LOGISTIEKE DIENSTEN Top 10 logistieke dienstverleners in Nederland 2006 Top 10 logistieke dienstverleners in Nederland 2011 Bron: www.logistiek.nl

CONSOLIDATIE IN SIERTEELTLOGISTIEK? Bron: www.logistiek.nl

Recommended

Mystery of the maya collapse

Mystery of the maya collapse

Mystery of the maya collapse

Albania Energy Association

Metro Campus:Geleyn Meijer, Economic Development Board Catch Up Sessie 24 jun...

Metro Campus:Geleyn Meijer, Economic Development Board Catch Up Sessie 24 jun...

Metro Campus:Geleyn Meijer, Economic Development Board Catch Up Sessie 24 jun...

KennisKring Amsterdam

Exergy on urban scale - Exergy conference Paris

Exergy on urban scale - Exergy conference Paris

Exergy on urban scale - Exergy conference Paris

HOU-eLearning - liemqv & minhbt

HOU-eLearning - liemqv & minhbt

HOU-eLearning - liemqv & minhbt

Case study on redundant enterprise energy management system - AVReporter

Case study on redundant enterprise energy management system - AVReporter

Case study on redundant enterprise energy management system - AVReporterAvreporter KONsys

Coronado Corporate Presentation - September 2011 Rodman and Renshaw Conference

Coronado Corporate Presentation - September 2011 Rodman and Renshaw Conference

Coronado Corporate Presentation - September 2011 Rodman and Renshaw Conference

ProActive Capital Resources Group

Coronado Biosciences is engaged in the development of novel immunotherapy biologic agents. The Company's two principal pharmaceutical product candidates in clinical development are: CNDO-201, a biologic for the treatment of autoimmune diseases, such as Crohn's disease, ulcerative colitis and multiple sclerosis; and CNDO-109, a biologic that activates natural killer cells, for the treatment of acute myeloid leukemia and solid tumors. The Company recently completed a $25.8 million round of financing and is using the proceeds to advance its pipeline, including funding Phase II double-blind, placebo controlled trial of CNDO-201 for the treatment of Crohn's Disease scheduled for initiation in early 2012 and a Phase I/II dose escalation and expansion trial of CNDO-109 for the treatment of relapsed Acute Myeloid Leukemia (AML) planned for 2012. Each of these drugs is a novel therapy that has achieved clinical proof-of-concept in indications with unmet medical needs.

я и школа успеха2

я и школа успеха2

я и школа успеха2Google

Grabbed early by vocabulary: Nation’s ongoing contributions to vocabulary

Grabbed early by vocabulary: Nation’s ongoing contributions to vocabulary

Grabbed early by vocabulary: Nation’s ongoing contributions to vocabularyJessica Jasso

Recommended

Mystery of the maya collapse

Mystery of the maya collapse

Mystery of the maya collapse

Albania Energy Association

Metro Campus:Geleyn Meijer, Economic Development Board Catch Up Sessie 24 jun...

Metro Campus:Geleyn Meijer, Economic Development Board Catch Up Sessie 24 jun...

Metro Campus:Geleyn Meijer, Economic Development Board Catch Up Sessie 24 jun...

KennisKring Amsterdam

Exergy on urban scale - Exergy conference Paris

Exergy on urban scale - Exergy conference Paris

Exergy on urban scale - Exergy conference Paris

HOU-eLearning - liemqv & minhbt

HOU-eLearning - liemqv & minhbt

HOU-eLearning - liemqv & minhbt

Case study on redundant enterprise energy management system - AVReporter

Case study on redundant enterprise energy management system - AVReporter

Case study on redundant enterprise energy management system - AVReporterAvreporter KONsys

Coronado Corporate Presentation - September 2011 Rodman and Renshaw Conference

Coronado Corporate Presentation - September 2011 Rodman and Renshaw Conference

Coronado Corporate Presentation - September 2011 Rodman and Renshaw Conference

ProActive Capital Resources Group

Coronado Biosciences is engaged in the development of novel immunotherapy biologic agents. The Company's two principal pharmaceutical product candidates in clinical development are: CNDO-201, a biologic for the treatment of autoimmune diseases, such as Crohn's disease, ulcerative colitis and multiple sclerosis; and CNDO-109, a biologic that activates natural killer cells, for the treatment of acute myeloid leukemia and solid tumors. The Company recently completed a $25.8 million round of financing and is using the proceeds to advance its pipeline, including funding Phase II double-blind, placebo controlled trial of CNDO-201 for the treatment of Crohn's Disease scheduled for initiation in early 2012 and a Phase I/II dose escalation and expansion trial of CNDO-109 for the treatment of relapsed Acute Myeloid Leukemia (AML) planned for 2012. Each of these drugs is a novel therapy that has achieved clinical proof-of-concept in indications with unmet medical needs.

я и школа успеха2

я и школа успеха2

я и школа успеха2Google

Grabbed early by vocabulary: Nation’s ongoing contributions to vocabulary

Grabbed early by vocabulary: Nation’s ongoing contributions to vocabulary

Grabbed early by vocabulary: Nation’s ongoing contributions to vocabularyJessica Jasso

Alliance Bernstein

Alliance Bernstein

Alliance Bernsteinshaunbarnes

MediaHartfordsam

Product portfolio 2013

Product portfolio 2013

Product portfolio 2013

Escalfament del planeta

Escalfament del planeta

Escalfament del planetaInstitut Quatre Cantons

BioNeutral Group (OTCBB: BONU; Twitter $BONU)

BioNeutral Group (OTCBB: BONU; Twitter $BONU)

BioNeutral Group (OTCBB: BONU; Twitter $BONU)

ProActive Capital Resources Group

BioNeutral Group (OTCBB: BONU) is a specialty technology-based life science company which has developed a technology platform that neutralizes harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses, mold, fungi and spores. BioNeutral's products, Ygiene™ and Ogiene™, kill germs and clean surfaces with a dramatic increase in speed and power over their rivals in the marketplace.

Smallbiz marketing

Smallbiz marketing

Smallbiz marketing

Startup Ingredients (Team, Solving a Problem, Customers)

Startup Ingredients (Team, Solving a Problem, Customers)

Startup Ingredients (Team, Solving a Problem, Customers)

Neostem Research Report by JMP Securites

Neostem Research Report by JMP Securites

Neostem Research Report by JMP Securites

ProActive Capital Resources Group

NeoStem, Inc. (AMEX: NBS; Stock Twits: $NBS) is engaged in the development and manufacturing of cell-based therapies in the U.S. Its January 2011 acquisition of Progenitor Cell Therapy, LLC ("PCT") is central to the Company's strategic mission of capturing the paradigm shift to cell therapy. The acquisition of PCT gives NeoStem not only access to a world class contract manufacturing cell therapy company but provides a platform and expertise around the evaluation, development and regulatory requirements to develop autologous, allogeneic, immunomodulatory and vaccine-based therapeutics. NeoStem also holds the worldwide exclusive license to VSEL(TM) Technology, which uses very small embryonic-like stem cells, shown to have several physical characteristics that are generally found in embryonic stem cells, and is pursuing the licensing of other technologies for therapeutic use. Headquartered in San Francisco, JMP Securities was founded in January 2000 in response to the consolidation of established independent research boutiques by large commercial banks. Since the mid-1990s nearly 50 regional investment banks—including San Francisco’s Montgomery Securities, Hambrecht & Quist and Robertson Stephens—have been acquired by major financial institutions. Such industry consolidation has pressured a new breed of bulge-bracket investment banks to compete for large market-capitalization clients and has greatly reduced Wall Street’s focus on the middle market. JMP Securities was formed in the mold of its independent, research-driven predecessors as a growth-oriented, entrepreneurial firm dedicated to serving the needs of small and midsized companies and the institutions that invest in them.

BioNeutral Group ($BONU) - June 2011 PowerPoint

BioNeutral Group ($BONU) - June 2011 PowerPoint

BioNeutral Group ($BONU) - June 2011 PowerPoint

ProActive Capital Resources Group

BioNeutral Group (OTCBB: BONU) is a specialty technology-based life science company which has developed a technology platform that neutralizes harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses, mold, fungi and spores. BioNeutral's products, Ygiene™ and Ogiene™, kill germs and clean surfaces with a dramatic increase in speed and power over their rivals in the marketplace.

Teknik menghasilkan blog 1

Teknik menghasilkan blog 1

Teknik menghasilkan blog 1

Fibrocell Science ($FCSC) - Rodman & Renshaw 2011

Fibrocell Science ($FCSC) - Rodman & Renshaw 2011

Fibrocell Science ($FCSC) - Rodman & Renshaw 2011

ProActive Capital Resources Group

Fibrocell Science, Inc. (OTCBB:FCSC.ob - News) is a biotechnology company focused on the development of regenerative cell therapy for aesthetic, medical and scientific applications. Fibrocell Science is committed to advancing the scientific, medical and commercial potential of autologous skin and tissue, as well as its innovative cellular processing technology and manufacturing excellence. For additional information, please visit www.fibrocellscience.com.

Paul Suijkerbuijk, Rob Bots, Frank Verschoor, Ministerie BZK

Paul Suijkerbuijk, Rob Bots, Frank Verschoor, Ministerie BZK

Paul Suijkerbuijk, Rob Bots, Frank Verschoor, Ministerie BZK

KennisKring Amsterdam

Business intelligence

Business intelligence

Business intelligence

Avreporter KONsys

InVivo Therapeutics Holdings Corp. (ONVIV.OB)

InVivo Therapeutics Holdings Corp. (ONVIV.OB)

InVivo Therapeutics Holdings Corp. (ONVIV.OB)ProActive Capital Resources Group

html help

Building the Ultimate Human Organisation (ArabNet, Beirut, 2016)

Building the Ultimate Human Organisation (ArabNet, Beirut, 2016)

Building the Ultimate Human Organisation (ArabNet, Beirut, 2016)

Session 1 energy course introduction

Session 1 energy course introduction

Session 1 energy course introduction

Albania Energy Association

Evaluation 3EDPRICE93

Roel Spits, Poseidon

Roel Spits, Poseidon

Roel Spits, Poseidon

KennisKring Amsterdam

Hans Haveman gemeente Enschede

Hans Haveman gemeente Enschede

Hans Haveman gemeente Enschede

KennisKring Amsterdam

Wilco Schuttelaar, Arjan in 't Veld, We Helpen

Wilco Schuttelaar, Arjan in 't Veld, We Helpen

Wilco Schuttelaar, Arjan in 't Veld, We Helpen

KennisKring Amsterdam

Martijn Kriens Amsterdam Economic Board

Martijn Kriens Amsterdam Economic Board

Martijn Kriens Amsterdam Economic Board

KennisKring Amsterdam

More Related Content

Viewers also liked

Alliance Bernstein

Alliance Bernstein

Alliance Bernsteinshaunbarnes

MediaHartfordsam

Product portfolio 2013

Product portfolio 2013

Product portfolio 2013

Escalfament del planeta

Escalfament del planeta

Escalfament del planetaInstitut Quatre Cantons

BioNeutral Group (OTCBB: BONU; Twitter $BONU)

BioNeutral Group (OTCBB: BONU; Twitter $BONU)

BioNeutral Group (OTCBB: BONU; Twitter $BONU)

ProActive Capital Resources Group

BioNeutral Group (OTCBB: BONU) is a specialty technology-based life science company which has developed a technology platform that neutralizes harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses, mold, fungi and spores. BioNeutral's products, Ygiene™ and Ogiene™, kill germs and clean surfaces with a dramatic increase in speed and power over their rivals in the marketplace.

Smallbiz marketing

Smallbiz marketing

Smallbiz marketing

Startup Ingredients (Team, Solving a Problem, Customers)

Startup Ingredients (Team, Solving a Problem, Customers)

Startup Ingredients (Team, Solving a Problem, Customers)

Neostem Research Report by JMP Securites

Neostem Research Report by JMP Securites

Neostem Research Report by JMP Securites

ProActive Capital Resources Group

NeoStem, Inc. (AMEX: NBS; Stock Twits: $NBS) is engaged in the development and manufacturing of cell-based therapies in the U.S. Its January 2011 acquisition of Progenitor Cell Therapy, LLC ("PCT") is central to the Company's strategic mission of capturing the paradigm shift to cell therapy. The acquisition of PCT gives NeoStem not only access to a world class contract manufacturing cell therapy company but provides a platform and expertise around the evaluation, development and regulatory requirements to develop autologous, allogeneic, immunomodulatory and vaccine-based therapeutics. NeoStem also holds the worldwide exclusive license to VSEL(TM) Technology, which uses very small embryonic-like stem cells, shown to have several physical characteristics that are generally found in embryonic stem cells, and is pursuing the licensing of other technologies for therapeutic use. Headquartered in San Francisco, JMP Securities was founded in January 2000 in response to the consolidation of established independent research boutiques by large commercial banks. Since the mid-1990s nearly 50 regional investment banks—including San Francisco’s Montgomery Securities, Hambrecht & Quist and Robertson Stephens—have been acquired by major financial institutions. Such industry consolidation has pressured a new breed of bulge-bracket investment banks to compete for large market-capitalization clients and has greatly reduced Wall Street’s focus on the middle market. JMP Securities was formed in the mold of its independent, research-driven predecessors as a growth-oriented, entrepreneurial firm dedicated to serving the needs of small and midsized companies and the institutions that invest in them.

BioNeutral Group ($BONU) - June 2011 PowerPoint

BioNeutral Group ($BONU) - June 2011 PowerPoint

BioNeutral Group ($BONU) - June 2011 PowerPoint

ProActive Capital Resources Group

BioNeutral Group (OTCBB: BONU) is a specialty technology-based life science company which has developed a technology platform that neutralizes harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses, mold, fungi and spores. BioNeutral's products, Ygiene™ and Ogiene™, kill germs and clean surfaces with a dramatic increase in speed and power over their rivals in the marketplace.

Teknik menghasilkan blog 1

Teknik menghasilkan blog 1

Teknik menghasilkan blog 1

Fibrocell Science ($FCSC) - Rodman & Renshaw 2011

Fibrocell Science ($FCSC) - Rodman & Renshaw 2011

Fibrocell Science ($FCSC) - Rodman & Renshaw 2011

ProActive Capital Resources Group

Fibrocell Science, Inc. (OTCBB:FCSC.ob - News) is a biotechnology company focused on the development of regenerative cell therapy for aesthetic, medical and scientific applications. Fibrocell Science is committed to advancing the scientific, medical and commercial potential of autologous skin and tissue, as well as its innovative cellular processing technology and manufacturing excellence. For additional information, please visit www.fibrocellscience.com.

Paul Suijkerbuijk, Rob Bots, Frank Verschoor, Ministerie BZK

Paul Suijkerbuijk, Rob Bots, Frank Verschoor, Ministerie BZK

Paul Suijkerbuijk, Rob Bots, Frank Verschoor, Ministerie BZK

KennisKring Amsterdam

Business intelligence

Business intelligence

Business intelligence

Avreporter KONsys

InVivo Therapeutics Holdings Corp. (ONVIV.OB)

InVivo Therapeutics Holdings Corp. (ONVIV.OB)

InVivo Therapeutics Holdings Corp. (ONVIV.OB)ProActive Capital Resources Group

html help

Building the Ultimate Human Organisation (ArabNet, Beirut, 2016)

Building the Ultimate Human Organisation (ArabNet, Beirut, 2016)

Building the Ultimate Human Organisation (ArabNet, Beirut, 2016)

Session 1 energy course introduction

Session 1 energy course introduction

Session 1 energy course introduction

Albania Energy Association

Evaluation 3EDPRICE93

Viewers also liked (18)

Alliance Bernstein

Alliance Bernstein

Alliance Bernstein

Media

Product portfolio 2013

Product portfolio 2013

Product portfolio 2013

Escalfament del planeta

Escalfament del planeta

Escalfament del planeta

BioNeutral Group (OTCBB: BONU; Twitter $BONU)

BioNeutral Group (OTCBB: BONU; Twitter $BONU)

BioNeutral Group (OTCBB: BONU; Twitter $BONU)

Smallbiz marketing

Smallbiz marketing

Smallbiz marketing

Startup Ingredients (Team, Solving a Problem, Customers)

Startup Ingredients (Team, Solving a Problem, Customers)

Startup Ingredients (Team, Solving a Problem, Customers)

Neostem Research Report by JMP Securites

Neostem Research Report by JMP Securites

Neostem Research Report by JMP Securites

BioNeutral Group ($BONU) - June 2011 PowerPoint

BioNeutral Group ($BONU) - June 2011 PowerPoint

BioNeutral Group ($BONU) - June 2011 PowerPoint

Teknik menghasilkan blog 1

Teknik menghasilkan blog 1

Teknik menghasilkan blog 1

Fibrocell Science ($FCSC) - Rodman & Renshaw 2011

Fibrocell Science ($FCSC) - Rodman & Renshaw 2011

Fibrocell Science ($FCSC) - Rodman & Renshaw 2011

Paul Suijkerbuijk, Rob Bots, Frank Verschoor, Ministerie BZK

Paul Suijkerbuijk, Rob Bots, Frank Verschoor, Ministerie BZK

Paul Suijkerbuijk, Rob Bots, Frank Verschoor, Ministerie BZK

Business intelligence

Business intelligence

Business intelligence

InVivo Therapeutics Holdings Corp. (ONVIV.OB)

InVivo Therapeutics Holdings Corp. (ONVIV.OB)

InVivo Therapeutics Holdings Corp. (ONVIV.OB)

html help

Building the Ultimate Human Organisation (ArabNet, Beirut, 2016)

Building the Ultimate Human Organisation (ArabNet, Beirut, 2016)

Building the Ultimate Human Organisation (ArabNet, Beirut, 2016)

Session 1 energy course introduction

Session 1 energy course introduction

Session 1 energy course introduction

Evaluation 3

More from KennisKring Amsterdam

Roel Spits, Poseidon

Roel Spits, Poseidon

Roel Spits, Poseidon

KennisKring Amsterdam

Hans Haveman gemeente Enschede

Hans Haveman gemeente Enschede

Hans Haveman gemeente Enschede

KennisKring Amsterdam

Wilco Schuttelaar, Arjan in 't Veld, We Helpen

Wilco Schuttelaar, Arjan in 't Veld, We Helpen

Wilco Schuttelaar, Arjan in 't Veld, We Helpen

KennisKring Amsterdam

Martijn Kriens Amsterdam Economic Board

Martijn Kriens Amsterdam Economic Board

Martijn Kriens Amsterdam Economic Board

KennisKring Amsterdam

Jos Blom Alliander

Jos Blom Alliander

Jos Blom Alliander

KennisKring Amsterdam

Dennis Meerburg OMALA

Dennis Meerburg OMALA

Dennis Meerburg OMALA

KennisKring Amsterdam

Marcel Elswijk, Energygo

Marcel Elswijk, Energygo

Marcel Elswijk, Energygo

KennisKring Amsterdam

31-01-2013 Thierry Thijssen, Coosto

31-01-2013 Thierry Thijssen, Coosto

31-01-2013 Thierry Thijssen, Coosto

KennisKring Amsterdam

Arnold Smeulders, directeur COMMIT

Arnold Smeulders, directeur COMMIT

Arnold Smeulders, directeur COMMIT

KennisKring Amsterdam

Job Witteman, directeur Amsterdam Internet Exchange

Job Witteman, directeur Amsterdam Internet Exchange

Job Witteman, directeur Amsterdam Internet Exchange

KennisKring Amsterdam

Jeroen Lotze, Unitmanager Vastgoed Haven Amsterdam

Jeroen Lotze, Unitmanager Vastgoed Haven Amsterdam

Jeroen Lotze, Unitmanager Vastgoed Haven Amsterdam

KennisKring Amsterdam

Sjoerd Soeters, gebiedsontwikkelaar Centrum en architect stadhuis Zaanstad

Sjoerd Soeters, gebiedsontwikkelaar Centrum en architect stadhuis Zaanstad

Sjoerd Soeters, gebiedsontwikkelaar Centrum en architect stadhuis Zaanstad

KennisKring Amsterdam

Barbara Visser, wethouder EZ gem. Zaanstad over ontwikkelingen Zaanstad

Barbara Visser, wethouder EZ gem. Zaanstad over ontwikkelingen Zaanstad

Barbara Visser, wethouder EZ gem. Zaanstad over ontwikkelingen Zaanstad

KennisKring Amsterdam

Dick Buschman, oprichter, eigenaar van ACHTUNG!

Dick Buschman, oprichter, eigenaar van ACHTUNG!

Dick Buschman, oprichter, eigenaar van ACHTUNG!

KennisKring Amsterdam

Alexander Kalkman, Marketingmanager MKB en grootzakelijke markt Vodafone

Alexander Kalkman, Marketingmanager MKB en grootzakelijke markt Vodafone

Alexander Kalkman, Marketingmanager MKB en grootzakelijke markt Vodafone

KennisKring Amsterdam

Prof. dr. Jouke van Dijk

Prof. dr. Jouke van Dijk

Prof. dr. Jouke van Dijk

KennisKring Amsterdam

Pieter Hameetman en Lars Falch, Energietransitie, 26-10-2011

Pieter Hameetman en Lars Falch, Energietransitie, 26-10-2011

Pieter Hameetman en Lars Falch, Energietransitie, 26-10-2011

KennisKring Amsterdam

Amsterdam Smart City

Amsterdam Smart City

Amsterdam Smart CityKennisKring Amsterdam

Robert van den Brink, Energietransitie, 26-10-2011

Robert van den Brink, Energietransitie, 26-10-2011

Robert van den Brink, Energietransitie, 26-10-2011

KennisKring Amsterdam

Jan de Boer, Energietransitie, 26-10-2011

Jan de Boer, Energietransitie, 26-10-2011

Jan de Boer, Energietransitie, 26-10-2011

KennisKring Amsterdam

More from KennisKring Amsterdam (20)

Roel Spits, Poseidon

Roel Spits, Poseidon

Roel Spits, Poseidon

Hans Haveman gemeente Enschede

Hans Haveman gemeente Enschede

Hans Haveman gemeente Enschede

Wilco Schuttelaar, Arjan in 't Veld, We Helpen

Wilco Schuttelaar, Arjan in 't Veld, We Helpen

Wilco Schuttelaar, Arjan in 't Veld, We Helpen

Martijn Kriens Amsterdam Economic Board

Martijn Kriens Amsterdam Economic Board

Martijn Kriens Amsterdam Economic Board

Jos Blom Alliander

Jos Blom Alliander

Jos Blom Alliander

Dennis Meerburg OMALA

Dennis Meerburg OMALA

Dennis Meerburg OMALA

Marcel Elswijk, Energygo

Marcel Elswijk, Energygo

Marcel Elswijk, Energygo

31-01-2013 Thierry Thijssen, Coosto

31-01-2013 Thierry Thijssen, Coosto

31-01-2013 Thierry Thijssen, Coosto

Arnold Smeulders, directeur COMMIT

Arnold Smeulders, directeur COMMIT

Arnold Smeulders, directeur COMMIT

Job Witteman, directeur Amsterdam Internet Exchange

Job Witteman, directeur Amsterdam Internet Exchange

Job Witteman, directeur Amsterdam Internet Exchange

Jeroen Lotze, Unitmanager Vastgoed Haven Amsterdam

Jeroen Lotze, Unitmanager Vastgoed Haven Amsterdam

Jeroen Lotze, Unitmanager Vastgoed Haven Amsterdam

Sjoerd Soeters, gebiedsontwikkelaar Centrum en architect stadhuis Zaanstad

Sjoerd Soeters, gebiedsontwikkelaar Centrum en architect stadhuis Zaanstad

Sjoerd Soeters, gebiedsontwikkelaar Centrum en architect stadhuis Zaanstad

Barbara Visser, wethouder EZ gem. Zaanstad over ontwikkelingen Zaanstad

Barbara Visser, wethouder EZ gem. Zaanstad over ontwikkelingen Zaanstad

Barbara Visser, wethouder EZ gem. Zaanstad over ontwikkelingen Zaanstad

Dick Buschman, oprichter, eigenaar van ACHTUNG!

Dick Buschman, oprichter, eigenaar van ACHTUNG!

Dick Buschman, oprichter, eigenaar van ACHTUNG!

Alexander Kalkman, Marketingmanager MKB en grootzakelijke markt Vodafone

Alexander Kalkman, Marketingmanager MKB en grootzakelijke markt Vodafone

Alexander Kalkman, Marketingmanager MKB en grootzakelijke markt Vodafone

Prof. dr. Jouke van Dijk

Prof. dr. Jouke van Dijk

Prof. dr. Jouke van Dijk

Pieter Hameetman en Lars Falch, Energietransitie, 26-10-2011

Pieter Hameetman en Lars Falch, Energietransitie, 26-10-2011

Pieter Hameetman en Lars Falch, Energietransitie, 26-10-2011

Amsterdam Smart City

Amsterdam Smart City

Amsterdam Smart City

Robert van den Brink, Energietransitie, 26-10-2011

Robert van den Brink, Energietransitie, 26-10-2011

Robert van den Brink, Energietransitie, 26-10-2011

Jan de Boer, Energietransitie, 26-10-2011

Jan de Boer, Energietransitie, 26-10-2011

Jan de Boer, Energietransitie, 26-10-2011

Innovatie in de Sierteelt & het Businessmodel, door Sander de Leeuw, 16 nov 2011

1. CONSOLIDATIE IN DE LOGISTIEK

2. ONTWIKKELINGEN IN LOGISTIEKE DIENSTEN Top 10 logistieke dienstverleners in Nederland 2006 Top 10 logistieke dienstverleners in Nederland 2011 Bron: www.logistiek.nl

3. CONSOLIDATIE IN SIERTEELTLOGISTIEK? Bron: www.logistiek.nl